Viewing Study NCT02918266


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2025-12-25 @ 2:24 PM
Study NCT ID: NCT02918266
Status: TERMINATED
Last Update Posted: 2019-06-14
First Post: 2016-09-27
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: TAK-071 Scopolamine-Induced Cognitive Impairment Study
Sponsor: Takeda
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-11-21
Start Date Type: None
Primary Completion Date: 2017-08-02
Primary Completion Date Type: ACTUAL
Completion Date: 2017-08-08
Completion Date Type: ACTUAL
First Submit Date: 2016-09-27
First Submit QC Date: None
Study First Post Date: 2016-09-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-08-01
Results First Submit QC Date: None
Results First Post Date: 2019-06-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-03-15
Last Update Post Date: 2019-06-14
Last Update Post Date Type: ACTUAL